163 related articles for article (PubMed ID: 33955704)
1. Expression of OPN3 in acral lentiginous melanoma and its associated with clinicohistopathologic features and prognosis.
Zeng W; Zhang W; Feng J; He X; Lu H
Immun Inflamm Dis; 2021 Sep; 9(3):840-850. PubMed ID: 33955704
[TBL] [Abstract][Full Text] [Related]
2. Preferentially expressed antigen in melanoma immunohistochemistry as an adjunct for differential diagnosis in acral lentiginous melanoma and acral nevi.
Hu J; Cai X; Lv JJ; Wan XC; Zeng XY; Feng ML; Dai B; Kong YY
Hum Pathol; 2022 Feb; 120():9-17. PubMed ID: 34800527
[TBL] [Abstract][Full Text] [Related]
3. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Ramani NS; Aung PP; Gu J; Sfamenos S; Sdringola-Maranga C; Nagarajan P; Tetzlaff MT; Curry JL; Ivan D; Diab A; Prieto VG; Hwu WJ; Torres-Cabala CA
Mod Pathol; 2020 Oct; 33(10):2067-2074. PubMed ID: 32404956
[TBL] [Abstract][Full Text] [Related]
4. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract][Full Text] [Related]
5. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
[TBL] [Abstract][Full Text] [Related]
6. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
Tas F; Erturk K
Am J Dermatopathol; 2022 Nov; 44(11):799-805. PubMed ID: 35925149
[TBL] [Abstract][Full Text] [Related]
7. Reflectance confocal microscopy features of acral lentiginous melanoma: a comparative study with acral nevi.
Cinotti E; Debarbieux S; Perrot JL; Labeille B; Long-Mira E; Habougit C; Douchet C; Depaepe L; Hammami-Ghorbel H; Lacour JP; Thomas L; Cambazard F; Bahadoran P;
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1125-8. PubMed ID: 26428577
[TBL] [Abstract][Full Text] [Related]
8. Anatomic mapping of acral melanocytic nevi and acral lentiginous melanomas among Taiwanese patients: A retrospective cohort study.
Chen SN; Lin MH; Liao YH; Liau JY; Chu CY; Sheen YS
J Formos Med Assoc; 2024 May; 123(5):587-593. PubMed ID: 37996319
[TBL] [Abstract][Full Text] [Related]
9. Distinctive dermatoscopic features of acral lentiginous melanoma in situ from plantar melanocytic nevi and their histopathologic correlation.
Kawabata Y; Tamaki K
J Cutan Med Surg; 1998 Apr; 2(4):199-204. PubMed ID: 9558302
[TBL] [Abstract][Full Text] [Related]
10. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
[TBL] [Abstract][Full Text] [Related]
11. High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma.
Zúñiga-Castillo M; Pereira NV; Sotto MN
Histopathology; 2018 Jun; 72(7):1189-1198. PubMed ID: 29415335
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Nagarajan P; Curry JL; Ciurea AM; Rubin AI; Hwu WJ; Prieto VG; Aung PP
Arch Pathol Lab Med; 2021 Aug; 145(8):943-952. PubMed ID: 33290520
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
14. Acral Lentiginous Melanoma: Survival Analysis of 715 Cases.
Lino-Silva LS; Zepeda-Najar C; Salcedo-Hernández RA; Martínez-Said H
J Cutan Med Surg; 2019; 23(1):38-43. PubMed ID: 30221995
[TBL] [Abstract][Full Text] [Related]
15. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and survival in acral lentiginous melanoma.
Asgari MM; Shen L; Sokil MM; Yeh I; Jorgenson E
Br J Dermatol; 2017 Aug; 177(2):428-435. PubMed ID: 28432682
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of the prognostic and oncogenic roles of OPN3 in human cancers.
Zhang W; Feng J; Zeng W; He Z; Yang W; Lu H
BMC Cancer; 2022 Feb; 22(1):187. PubMed ID: 35180853
[TBL] [Abstract][Full Text] [Related]
18. Acral lentiginous melanoma. A histological type without prognostic significance.
Cascinelli N; Zurrida S; Galimberti V; Bartoli C; Bufalino R; Del Prato I; Mascheroni L; Testori A; Clemente C
J Dermatol Surg Oncol; 1994 Dec; 20(12):817-22. PubMed ID: 7798414
[TBL] [Abstract][Full Text] [Related]
19. Acral lentiginous melanoma in the Turkish population and a new dermoscopic clue for the diagnosis.
Ozdemir F; Errico MA; Yaman B; Karaarslan I
Dermatol Pract Concept; 2018 Apr; 8(2):140-148. PubMed ID: 29785333
[TBL] [Abstract][Full Text] [Related]
20. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
